Canada is the second country in the world to legalize cannabis for non-medical use. This decision offers researchers an unprecedented opportunity to study the impacts of cannabis use in a legalized environment— including its effects on mental health. To seize that opportunity, the federal government has allocated $10 million to the Mental Health Commission of Canada (MHCC) over the next five years to investigate the risks and benefits of cannabis as well as the varying needs of diverse subpopulations of people living in Canada.
- Cannabis and Mental Health: Priorities for Research in Canada
- Closing the Research Gap on Cannabis and Mental Health
In partnership with the Canadian Institutes of Health Research and the Canadian Centre on Substance Use and Addiction
Catalyst Grants (one year maximum of $125,000) A total of $750,000 has been set aside to fund applications relevant to cannabis and mental health. These catalyst grants are meant to build research capacity and inform the development of future, larger scale research projects
- Team Grants (five years)
In July 2019, the MHCC gathered a diverse group of experts, including people with lived experience of substance use and/or mental health problems and illnesses, service providers, family members, community-based researchers and policy makers, to discuss funding priorities for community-based research on cannabis and mental health. Our Shaping Future Investments in Community-Based Research on Cannabis and Mental Health report gives a concise account of the day’s discussions as well as key takeaways.